These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 3842892

  • 21. [Anti-blastic properties of berberine and its derivatives].
    Shvarev IF, Tsetlin AL.
    Farmakol Toksikol; 1972; 35(1):73-5. PubMed ID: 5011522
    [No Abstract] [Full Text] [Related]

  • 22. [Therapeutic effect of berberine on 60 patients with type II diabetes mellitus and experimental research].
    Ni YX.
    Zhong Xi Yi Jie He Za Zhi; 1988 Dec; 8(12):711-3, 707. PubMed ID: 3248329
    [No Abstract] [Full Text] [Related]

  • 23. Antitumor activity of berberrubine derivatives.
    Hoshi A, Ikekawa T, Ikeda Y, Shirakawa S, Iigo M.
    Gan; 1976 Apr; 67(2):321-5. PubMed ID: 964560
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge.
    Pal S, Peterson EM, Rappuoli R, Ratti G, de la Maza LM.
    Vaccine; 2006 Feb 06; 24(6):766-75. PubMed ID: 16199110
    [Abstract] [Full Text] [Related]

  • 26. Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.
    Ifere GO, He Q, Igietseme JU, Ananaba GA, Lyn D, Lubitz W, Kellar KL, Black CM, Eko FO.
    J Microbiol Immunol Infect; 2007 Jun 06; 40(3):188-200. PubMed ID: 17639158
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Constant ocular infection with Chlamydia trachomatis predicts risk of scarring in children in Tanzania.
    Wolle MA, Muñoz BE, Mkocha H, West SK.
    Ophthalmology; 2009 Feb 06; 116(2):243-7. PubMed ID: 19091415
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [1-SPD, a new dopamine receptors blocker, in treating vascular headache].
    Le WD, Zhou XD, Wang WJ.
    Zhonghua Nei Ke Za Zhi; 1987 Dec 06; 26(12):681-4, 741. PubMed ID: 3451849
    [No Abstract] [Full Text] [Related]

  • 32. A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes.
    Macmillan L, Ifere GO, He Q, Igietseme JU, Kellar KL, Okenu DM, Eko FO.
    FEMS Immunol Med Microbiol; 2007 Feb 06; 49(1):46-55. PubMed ID: 17094789
    [Abstract] [Full Text] [Related]

  • 33. Trachoma.
    Mabey D, Fraser-Hurt N.
    BMJ; 2001 Jul 28; 323(7306):218-21. PubMed ID: 11473918
    [No Abstract] [Full Text] [Related]

  • 34. A peptide of Chlamydia trachomatis shown to be a primary T-cell epitope in vitro induces cell-mediated immunity in vivo.
    Knight SC, Iqball S, Woods C, Stagg A, Ward ME, Tuffrey M.
    Immunology; 1995 May 28; 85(1):8-15. PubMed ID: 7543450
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Seroepidemiologic study of Chlamydia pneumoniae and other chlamydial species in a hyperendemic area for trachoma in the Sudan.
    Mahmoud E, Elshibly S, Mardh PA.
    Am J Trop Med Hyg; 1994 Oct 28; 51(4):489-94. PubMed ID: 7943577
    [Abstract] [Full Text] [Related]

  • 37. Immunogenicity evaluation of a lipidic amino acid-based synthetic peptide vaccine for Chlamydia trachomatis.
    Zhong G, Toth I, Reid R, Brunham RC.
    J Immunol; 1993 Oct 01; 151(7):3728-36. PubMed ID: 7690812
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.